Neptune Technologies & Bioressources Inc. Reports Third Quarter Results

LAVAL, QC, April 26, 2006 /PRNewswire-FirstCall via COMTEX/ -- Neptune Technologies & Bioressources Inc., (TSX Venture Exchange: NTB), "Neptune" today announced its results for the Third quarter ended February 28, 2006.
Neptune's Highlights:

- Third Quarter ended February 28, 2006:

- Revenues increased 41% to $1,822,000 compared to $1,292,000 for
last year's third quarter.

- EBITDA increased 144% to $286,000 compared to $117,000 for Q3F05

- EBITDA reached 15.7% of sales compared to 9% for Q3F05.

- Neptune realized a net profit of $1,038,000 or $0.032 per share
for the quarter, mainly due to a one time gain on debt settlement
on debentures.

- Excluding the one time gain, net loss was $362,000 or $0.010 per
share compared to $344,000 or $0.013 per share, for last year's
third quarter.

- Nine months ended February 28, 2006.

- Revenues increased 41% to $5,089,000 compared to $3,606,000 last

- EBITDA increased 125% to $873,000 representing 17.2% of sales
compared to $387,000 last year or 10.7% of sales.

- Excluding the one time gain of $1.4M, our net loss was $1,132,000
or $0.039 per share, compared to $1,235,000 or $0.049
per share last year.

- Net profit for the period was $268,000 or $0.009 per share.

"We are very pleased with this quarter's performance. The debentures settlement resulted in an extraordinary gain of $1.4M," stated Mr. Andre Godin Vice President, Administration and Finance for Neptune. "The debenture settlement has greatly improved Neptune's capital structure, for instance, our long term debt ratio has reduced from 119% to 39%. The bottom line pressure is now relieved by more than $840,000 of annual interest expenses. This positive impact will continue to be evident in future results, which we believe, will have a positive impact on shareholder value" added Mr. Godin.

About Neptune Technologies & Bioressources Inc.
Neptune Technologies & Bioressources Inc. develops high value added nutritional products from underexploited marine biomasses, such as krill, with its patented extraction process (Neptune OceanExtract(TM)). Using an exclusive process, Neptune Technologies & Bioressources Inc. is well positioned in the $182 billion global nutrition market (Nutrition Business Journal, Oct/Nov 2004) of health and wellness concepts.

Natural biomass extraction is now playing an important role in developing nutrigenomics, the next wave in nutritional research. Through strategic alliances and partnerships, as well as through clinical studies, the Company continues to demonstrate the immense beneficial effects of these products. The Company develops and markets new formulas and new products for specific applications in high growth markets such the nutraceutical, cosmeceutical, biopharmaceutical and nutrigenomics markets.

The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this press release.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.